speb/financial-data huggingface dataset:
CVE.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 6314000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Current Provisions: 26000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Current Provisions: 26000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -231000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 289000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -231000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 289000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 5192000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1372000000.00
CVE.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 1819861000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 1836094000.00
CVE.TO income_statement (annual, 2025-12-31) — Diluted EPS: 2.15
CVE.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.50
CVE.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 3916000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 933000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 135000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 25000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 36000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 36000000.00
CVE.TO income_statement (annual, 2025-12-31) — EBIT: 5138000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — EBIT: 1220000000.00
CVE.TO income_statement (annual, 2025-12-31) — EBITDA: 10330000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — EBITDA: 2592000000.00
CVE.TO income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 53000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 8000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -53000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -8000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -155000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -73000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 429000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 429000000.00
CVE.TO cash_flow (annual, 2025-12-31) — End Cash Position: 2740000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 2740000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -749000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 2142000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 2877000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 2877000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 3321000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 1048000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -15000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 50000000.00
CVE.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 87000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -22000000.00
CVE.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 398000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 123000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 401000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 401000000.00
CVE.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 812000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 242000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Goodwill: 2912000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 2912000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2935000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2935000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 79039000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 79039000000.00
CVE.TO income_statement (annual, 2025-12-31) — Gross Profit: 11816000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 2788000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 98000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 98000000.00
CVE.TO income_statement (annual, 2025-12-31) — Interest Expense: 661000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 186000000.00
CVE.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 661000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 186000000.00
CVE.TO income_statement (annual, 2025-12-31) — Interest Income: 132000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Interest Income: 21000000.00
CVE.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 132000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 21000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Interest Payable: 80000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Interest Payable: 80000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Inventory: 3349000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 3349000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 42541000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 42541000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -7677000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -3638000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 552000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 552000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 193000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 193000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Investmentsin Joint Venturesat Cost: 295000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Investmentsin Joint Venturesat Cost: 295000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 5265000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Leases: 611000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Leases: 611000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Line Of Credit: 0.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 0.00
CVE.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2806000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2806000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 11032000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 11032000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13838000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13838000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 5265000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2674000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -2213000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 488000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 488000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 4955000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 4955000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 16000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 16000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -2527000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -2304000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -2150000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -775000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Net Debt: 8292000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 8292000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -401000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -157000000.00
CVE.TO income_statement (annual, 2025-12-31) — Net Income: 3930000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Net Income: 934000000.00
CVE.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 3916000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 932000000.00
CVE.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 3930000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 934000000.00
CVE.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3930000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 934000000.00
CVE.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3930000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 934000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 3930000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 934000000.00
CVE.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 3930000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 934000000.00
CVE.TO income_statement (annual, 2025-12-31) — Net Interest Income: -569000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -165000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -7000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 2000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 2743000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 3052000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 2591000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 3052000000.00
CVE.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -569000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -165000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 413000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 230000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -236000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 24000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Net PPE: 47988000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 47988000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: -350000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
CVE.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 152000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CVE.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 28687000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 28687000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 155000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 155000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 1594000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1594000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 5873000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 5873000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 1594000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1594000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 5873000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 5873000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 260000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 260000000.00
CVE.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 10079000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 2602000000.00
CVE.TO income_statement (annual, 2025-12-31) — Normalized Income: 3709622000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 943032882.01
CVE.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 8228000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 2408000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -556000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -93000000.00
CVE.TO income_statement (annual, 2025-12-31) — Operating Income: 4627000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Operating Income: 1140000000.00
CVE.TO income_statement (annual, 2025-12-31) — Operating Revenue: 52751000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 13938000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1883400091.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1883400091.00
CVE.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 401000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 401000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Other Equity Interest: 4000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 4000000.00
CVE.TO income_statement (annual, 2025-12-31) — Other Gand A: 339000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Other Gand A: -231000000.00
CVE.TO income_statement (annual, 2025-12-31) — Other Income Expense: 419000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 59000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 23000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 23000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Other Investments: 64000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Other Investments: 64000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -42000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -4000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 310000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 310000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 377000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 377000000.00
CVE.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 115000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 61000000.00
CVE.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 6377000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1406000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Other Payable: 66000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 66000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Other Properties: 4716000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 4716000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 93000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 93000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Payables: 5666000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Payables: 5666000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 5756000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 5756000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 163000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 163000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 12000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 12000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Preferred Stock: 113000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 113000000.00
CVE.TO income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 14000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 2000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 113000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 113000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Preferred Stock Payments: -350000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Preferred Stock Payments: 0.00
CVE.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 260000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 260000000.00
CVE.TO income_statement (annual, 2025-12-31) — Pretax Income: 4477000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 1034000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 32000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 15000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: -4418000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -4182000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 472000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 472000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Receivables: 3541000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 3541000000.00
CVE.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 40935000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 11150000000.00
CVE.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 5192000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1372000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2674000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -2213000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -2500000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -775000000.00
CVE.TO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 234000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 111000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 12323000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 12323000000.00
CVE.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 473000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 1891000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Sale Of Business: 1878000000.00
CVE.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 812000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 242000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Share Issued: 1888658091.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 1888658091.00
CVE.TO income_statement (annual, 2025-12-31) — Special Income Charges: -147000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: -133000000.00
CVE.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 163000000.00
CVE.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 69000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 31622000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 31622000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 28574000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 28574000000.00
CVE.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 30622000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -967117.99
CVE.TO income_statement (annual, 2025-12-31) — Tax Provision: 547000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 100000000.00
CVE.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.12
CVE.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.10
CVE.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 366000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 366000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Total Assets: 63424000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 63424000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 42654000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 42654000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Total Debt: 14207000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 14207000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 31638000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 31638000000.00
CVE.TO income_statement (annual, 2025-12-31) — Total Expenses: 48124000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 12798000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 31786000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 31786000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 53534000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 53534000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 25472000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 25472000000.00
CVE.TO income_statement (annual, 2025-12-31) — Total Other Finance Cost: 40000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 0.00
CVE.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 98000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 98000000.00
CVE.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 251000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -10000000.00
CVE.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 251000000.00
CVE.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -10000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 5258000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 5258000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Treasury Stock: 116000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 116000000.00
CVE.TO balance_sheet (annual, 2025-12-31) — Working Capital: 3576000000.00
CVE.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 3576000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 1886000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 13339000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 6691000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4734000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -32580000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 292000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: 0.00
CVE.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 1874914000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.84
CVE.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 2740000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1170000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -1170000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3119000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 18544000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2575000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2575000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -379000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1335000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1070000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 2181000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1143000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -224000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 18544000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -377000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 32517000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -356000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 9094000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 11477000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 374000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 374000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 7330000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -33000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: -33000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 1471000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1471000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1471000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 1879053000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.83
CVE.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1568000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 22000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — EBIT: 2292000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — EBITDA: 3763000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 15000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -15000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 59000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 414000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 2575000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1335000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 1011000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -1000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 86000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -188000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 650000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 411000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 2912000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2912000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 80378000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 4245000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 265000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 208000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 208000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Interest Income: 26000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 26000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 4127000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 43150000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1070000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 291000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 291000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Leases: 610000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 2745000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 10633000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 13378000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -590000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 291000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 4977000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 16000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 89000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -356000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 8058000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 180000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Net Income: 1570000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1568000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1570000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1570000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1570000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1570000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1570000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -194000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 12000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -590000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -590000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -194000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 294000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -1000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 47798000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Preferred Stock Issuance: -300000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 29605000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 25000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 1541000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 5764000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1541000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 5764000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 259000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 3897000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 1670902000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 2181000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 78000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Operating Income: 2359000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 13339000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1871502000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 650000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 411000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -81000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 6000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 804000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 452000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 38000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1475000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 4768000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Payables: 6956000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 6956000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -2000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 2000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Preferred Stock Payments: -300000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 2084000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: -4000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -10000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 4775000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 9094000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1471000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -590000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -656000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 32000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 13118000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Sale Of Business: 99000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 411000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 1875001000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: 54000000.00
CVE.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 210000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 32517000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 29605000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -33098000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 514000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
CVE.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 41000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 64848000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 43150000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 13752000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 32533000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 10980000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 32315000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 53371000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 24985000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 12000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 265000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -134000000.00
CVE.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -134000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 3499000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 87000000.00
CVE.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 4147000000.00
CVEO balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 11762000.00
CVEO income_statement (annual, 2021-12-31) — Average Dilution Earnings: 0.00
CVEO balance_sheet (annual, 2021-12-31) — Current Debt: 30576000.00
CVEO balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 30576000.00
CVEO cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
CVEO cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -5532000.00
CVEO cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 559000.00
CVEO cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 0.00
CVEO cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 49157000.00
CVEO balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 30576000.00
CVEO income_statement (annual, 2021-12-31) — Other Special Charges: 416000.00
CVEO income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 0.00
CVEO balance_sheet (annual, 2021-12-31) — Preferred Stock: 61941000.00
CVEO income_statement (annual, 2021-12-31) — Preferred Stock Dividends: 1925000.00
CVEO balance_sheet (annual, 2021-12-31) — Preferred Stock Equity: 61941000.00
CVEO cash_flow (annual, 2021-12-31) — Preferred Stock Payments: 0.00
CVEO cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
CVEO income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 13960000.00
CVEO cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 397952000.00
CVEO cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -348795000.00
CVEO balance_sheet (annual, 2021-12-31) — Work In Process: 25000.00
CVEO income_statement (annual, 2022-12-31) — +Operating Expense: 157250000.00
CVEO income_statement (annual, 2022-12-31) — +Total Revenue: 697052000.00
CVEO balance_sheet (annual, 2022-12-31) — Accounts Payable: 51087000.00
CVEO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 65563000.00
CVEO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1288312000.00
CVEO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1624512000.00
CVEO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 5721000.00
CVEO balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 8653000.00
CVEO income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
CVEO income_statement (annual, 2022-12-31) — Basic Average Shares: 14002000.00
CVEO income_statement (annual, 2022-12-31) — Basic EPS: -0.21
CVEO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 6282000.00
CVEO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 15516000.00
CVEO cash_flow (annual, 2022-12-31) — Capital Expenditure: -25421000.00
CVEO cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -25421000.00
CVEO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 12771000.00
CVEO balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
CVEO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 7954000.00
CVEO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 7954000.00
CVEO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
CVEO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -79656000.00
CVEO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -8945000.00
CVEO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 91773000.00
CVEO cash_flow (annual, 2022-12-31) — Change In Account Payable: 12323000.00
CVEO cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 5000.00
CVEO cash_flow (annual, 2022-12-31) — Change In Inventory: -1845000.00
CVEO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -9960000.00
CVEO cash_flow (annual, 2022-12-31) — Change In Payable: 12328000.00
CVEO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 12328000.00
CVEO cash_flow (annual, 2022-12-31) — Change In Receivables: -14447000.00
CVEO cash_flow (annual, 2022-12-31) — Change In Tax Payable: 5000.00
CVEO cash_flow (annual, 2022-12-31) — Change In Working Capital: -13924000.00
CVEO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -14447000.00
CVEO cash_flow (annual, 2022-12-31) — Changes In Cash: 3172000.00
CVEO balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
CVEO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
CVEO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 300139000.00
CVEO cash_flow (annual, 2022-12-31) — Common Stock Payments: -14209000.00
CVEO balance_sheet (annual, 2022-12-31) — Construction In Progress: 1771000.00
CVEO income_statement (annual, 2022-12-31) — Cost Of Revenue: 517063000.00
CVEO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1980000.00
CVEO balance_sheet (annual, 2022-12-31) — Current Assets: 153549000.00
CVEO balance_sheet (annual, 2022-12-31) — Current Debt: 28448000.00
CVEO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 28448000.00
CVEO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 991000.00
CVEO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 991000.00
CVEO balance_sheet (annual, 2022-12-31) — Current Liabilities: 128257000.00
CVEO cash_flow (annual, 2022-12-31) — Deferred Income Tax: 4177000.00
CVEO cash_flow (annual, 2022-12-31) — Deferred Tax: 4177000.00
CVEO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 87214000.00
CVEO income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 87214000.00
CVEO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 87214000.00
CVEO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 87214000.00
CVEO income_statement (annual, 2022-12-31) — Diluted Average Shares: 14002000.00
CVEO income_statement (annual, 2022-12-31) — Diluted EPS: -0.21
CVEO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -2963000.00
CVEO income_statement (annual, 2022-12-31) — EBIT: 22206000.00
CVEO income_statement (annual, 2022-12-31) — EBITDA: 109420000.00
CVEO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -1500000.00
CVEO cash_flow (annual, 2022-12-31) — End Cash Position: 7954000.00
CVEO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -79656000.00
CVEO balance_sheet (annual, 2022-12-31) — Finished Goods: 5538000.00
CVEO cash_flow (annual, 2022-12-31) — Free Cash Flow: 66352000.00
CVEO income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 0.00
CVEO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -385187000.00
CVEO balance_sheet (annual, 2022-12-31) — Goodwill: 7672000.00
CVEO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 89419000.00
CVEO balance_sheet (annual, 2022-12-31) — Gross PPE: 1605924000.00
CVEO income_statement (annual, 2022-12-31) — Gross Profit: 179989000.00
CVEO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 5721000.00
CVEO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 220000.00
CVEO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 178000.00
CVEO income_statement (annual, 2022-12-31) — Interest Expense: 11474000.00
CVEO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 11474000.00
CVEO income_statement (annual, 2022-12-31) — Interest Income: 39000.00
CVEO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 39000.00
CVEO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 9226000.00
CVEO balance_sheet (annual, 2022-12-31) — Inventory: 6907000.00
CVEO balance_sheet (annual, 2022-12-31) — Invested Capital: 431092000.00
CVEO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -8945000.00
CVEO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 289705000.00
CVEO balance_sheet (annual, 2022-12-31) — Land And Improvements: 25528000.00
CVEO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 12771000.00
CVEO balance_sheet (annual, 2022-12-31) — Long Term Debt: 102505000.00
CVEO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 115276000.00
CVEO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 289705000.00
CVEO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -323521000.00
CVEO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 82911000.00
CVEO balance_sheet (annual, 2022-12-31) — Minority Interest: 3562000.00
CVEO income_statement (annual, 2022-12-31) — Minority Interests: -2333000.00
CVEO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -14209000.00
CVEO balance_sheet (annual, 2022-12-31) — Net Debt: 122999000.00
CVEO income_statement (annual, 2022-12-31) — Net Income: 3997000.00
CVEO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -2963000.00
CVEO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6330000.00
CVEO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 3997000.00
CVEO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 3997000.00
CVEO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6330000.00
CVEO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6330000.00
CVEO income_statement (annual, 2022-12-31) — Net Interest Income: -11435000.00
CVEO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -33816000.00
CVEO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -33816000.00
CVEO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -11435000.00
CVEO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1078000.00
CVEO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 190000.00
CVEO balance_sheet (annual, 2022-12-31) — Net PPE: 317612000.00
CVEO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 16286000.00
CVEO cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: -30553000.00
CVEO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 210720000.00
CVEO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4778000.00
CVEO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4778000.00
CVEO income_statement (annual, 2022-12-31) — Normalized EBITDA: 115141000.00